Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *


ATC
ATC Description

ATC

ATC Code ATC Description
L01EA L01EA BCR-ABL tyrosine kinase inhibitors
L01EA01 L01EA01 Imatinib
L01EA02 L01EA02 Dasatinib
L01EA04 L01EA04 Bosutinib
L01EB L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
L01EB01 L01EB01 Gefitinib
L01EB02 L01EB02 Erlotinib
L01EB03 L01EB03 Afatinib
L01EB04 L01EB04 Osimertinib
L01EB05 L01EB05 Rociletinib
L01EB06 L01EB06 Olmutinib
L01EB07 L01EB07 Dacomitinib
L01EB08 L01EB08 Icotinib
L01EB09 L01EB09 Lazertinib
L01EB10 L01EB10 Mobocertinib
L01EB11 L01EB11 Aumolertinib
L01EC L01EC B-Raf serine-threonine kinase (BRAF) inhibitors
L01EC02 L01EC02 Dabrafenib
L01EC03 L01EC03 Encorafenib
L01ED L01ED Anaplastic lymphoma kinase (ALK) inhibitors
L01ED02 L01ED02 Ceritinib
L01ED04 L01ED04 Brigatinib
L01EE L01EE Mitogen-activated protein kinase (MEK) inhibitors
L01EE01 L01EE01 Trametinib
L01EE02 L01EE02 Cobimetinib
L01EE03 L01EE03 Binimetinib
L01EF L01EF Cyclin-dependent kinase (CDK) inhibitors
L01EF01 L01EF01 Palbociclib
L01EF02 L01EF02 Ribociclib
L01EF03 L01EF03 Abemaciclib
Showing 30 of 6884 Records